Ray Adrian S. 4

4 · Third Harmonic Bio, Inc. · Filed Mar 8, 2023

Form 4

Period: 2023-03-06

Chief Scientific Officer

Transactions

Disposition to Issuer
Employee Stock Option (right to buy)
2023-03-06−95,000→ 0 total
Exercise: $18.40Exp: 2032-10-24→ Common Stock (95,000 underlying)
Award
Employee Stock Option (right to buy)
2023-03-06+132,000→ 132,000 total
Exercise: $4.20Exp: 2033-03-05→ Common Stock (132,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2023-03-06−309,871→ 0 total
Exercise: $9.22Exp: 2032-04-01→ Common Stock (309,871 underlying)
Award
Employee Stock Option (right to buy)
2023-03-06+309,871→ 309,871 total
Exercise: $4.20Exp: 2032-04-01→ Common Stock (309,871 underlying)
Award
Employee Stock Option (right to buy)
2023-03-06+95,000→ 95,000 total
Exercise: $4.20Exp: 2032-10-24→ Common Stock (95,000 underlying)

Footnotes (4)

[F1]The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
[F2]6.25% of the total shares vested on April 1, 2022, and thereafter 6.25% of the total shares underlying the award shall vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
[F3]The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
[F4]The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.

Documents

1 file